Hyphens Pharma International Limited, often referred to as Hyphens Pharma, is a prominent player in the pharmaceutical and healthcare industry, headquartered in Singapore (SG). Established in 2001, the company has made significant strides in providing innovative healthcare solutions across Asia, with a focus on specialty pharmaceuticals and consumer health products. Hyphens Pharma is renowned for its unique portfolio, which includes prescription medicines, over-the-counter products, and nutraceuticals. The company distinguishes itself through strategic partnerships and a commitment to quality, ensuring that its offerings meet the highest standards of efficacy and safety. With a strong market position, Hyphens Pharma has achieved notable milestones, including expanding its operational reach and enhancing its product line to cater to diverse healthcare needs.
How does Hyphens Pharma International Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Hyphens Pharma International Limited's score of 28 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Hyphens Pharma International Limited reported total carbon emissions of approximately 470,200 kg CO2e, comprising 26,200 kg CO2e from Scope 1 and 444,000 kg CO2e from Scope 2 emissions. This marks an increase from 2023, when the company recorded total emissions of about 408,700 kg CO2e, with 10,700 kg CO2e from Scope 1 and 398,000 kg CO2e from Scope 2. Hyphens Pharma has not disclosed any Scope 3 emissions data, nor have they set specific reduction targets or initiatives as part of their climate commitments. The company’s emissions data is not cascaded from any parent organization, indicating that these figures are independently reported. The GHG emissions intensity for Hyphens Pharma stands at approximately 0.0024 tCO2e per million USD in revenue for both 2023 and 2024. As the company continues to operate, it remains essential for them to establish clear climate goals and reduction strategies to align with industry standards and expectations.
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 10,700 | 00,000 |
| Scope 2 | 398,000 | 000,000 |
| Scope 3 | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hyphens Pharma International Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
